Skip to main content
Clinical Trials/NCT06626490
NCT06626490
Recruiting
N/A

Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants

Aesculap AG3 sites in 2 countries120 target enrollmentApril 7, 2026

Overview

Phase
N/A
Intervention
Not specified
Conditions
Revision Total Hip Arthroplasty
Sponsor
Aesculap AG
Enrollment
120
Locations
3
Primary Endpoint
Functional outcome of the hip revision surgery
Status
Recruiting
Last Updated
9 days ago

Overview

Brief Summary

The study design is confirmative for non-inferiority of the functional outcome of the implants and is intended to examine the safety and performance of the Prevision hip stem. The study is an observational post-market clinical follow-up study, and the study sites chose the stem variant depending on their own routine and indication.

Detailed Description

Generally, the advantage of the Prevision implant family is that all implant variants can be implanted with basically the same instrumentation, which makes it easier to switch to another variant. All implant variants will be available at the study sites and switching between the variants in the study will be encouraged. The aim of the study is to prove the non-inferiority of the OHS functional outcome after two years to the predecessor implant generation, and comparable revision hip stems. In addition, the patient groups treated with the different variants, and outcome of these subgroups will be descriptively compared.

Registry
clinicaltrials.gov
Start Date
April 7, 2026
End Date
March 1, 2034
Last Updated
9 days ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Revision hip arthroplasty patients treated with a Prevision hip stem
  • Written patient informed consent
  • Patients are able to attend at follow-up examinations

Exclusion Criteria

  • Patients \< 18 years at surgery
  • Pregnancy at implantation
  • Patients held in a custodial setting
  • Patients in a relationship of dependence on the sponsor, the clinic or the investigator

Outcomes

Primary Outcomes

Functional outcome of the hip revision surgery

Time Frame: after two years

Oxford Hip Score:The Oxford Hip Score (OHS) is a joint-specific, patient-reported outcome measure designed to assess disability in patients undergoing total hip replacement (THR)

Secondary Outcomes

  • Kaplan-Meier survival(after two years)
  • EQ-5D-5L Quality of Life(visits after 2 and 5 years)
  • Complications(visits after 2 and 5 years)
  • Patient satisfaction(visits after 2 and 5 years)
  • Pain (VAS Score)(visits after 2 and 5 years)
  • Radiology: Hip stem subsidence(visits after 2 and 5 years)
  • Qualitative radiologic assessment(visits after 2 and 5 years)

Study Sites (3)

Loading locations...

Similar Trials